(ICE) Intercontinental Exchange - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US45866F1049
Stock: Exchanges, Data, Clearing, Analytics, Indices, Mortgage
Total Rating 43
Risk 71
Buy Signal -0.08
| Risk 5d forecast | |
|---|---|
| Volatility | 22.4% |
| Relative Tail Risk | -5.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha | -18.15 |
| Character TTM | |
|---|---|
| Beta | 0.335 |
| Beta Downside | 0.476 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.53% |
| CAGR/Max DD | 0.83 |
EPS (Earnings per Share)
Revenue
Description: ICE Intercontinental Exchange March 02, 2026
Intercontinental Exchange, Inc. (NYSE: ICE) operates a global network of regulated marketplaces and clearing houses, delivering technology, data, and workflow solutions across three segments: Exchanges, Fixed Income & Data Services, and Mortgage Technology.
In FY 2025 the company reported total revenue of $9.2 billion, up 8 % year-over-year, with an operating margin of 34 %, driven largely by growth in its derivatives exchange business and expanding data-service contracts.
Key sector catalysts include persistent interest-rate volatility that fuels demand for futures and swaps trading, heightened regulatory scrutiny that boosts the need for high-quality reference data, and a tightening U.S. residential-mortgage market that accelerates adoption of ICE’s digital mortgage-workflow platform.
For a deeper dive into ICE’s valuation metrics, you might explore ValueRay’s analyst tools.
Headlines to watch out for
- Global trading volumes impact exchange revenue
- Interest rate changes affect fixed income segment
- Mortgage technology adoption drives growth
- Regulatory changes influence market operations
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 3.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: 13.15% < 20% (prev -3.89%; Δ 17.05% < -1%) |
| CFO/TA 0.03 > 3% & CFO 4.66b > Net Income 3.30b |
| Net Debt (19.44b) to EBITDA (6.66b): 2.92 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (571.1m) vs 12m ago -1.02% < -2% |
| Gross Margin: 61.88% > 18% (prev 0.55%; Δ 6.13k% > 0.5%) |
| Asset Turnover: 9.15% > 50% (prev 8.44%; Δ 0.71% > 0%) |
| Interest Coverage Ratio: 6.53 > 6 (EBITDA TTM 6.66b / Interest Expense TTM 781.0m) |
Altman Z'' 1.01
| A: 0.01 (Total Current Assets 85.78b - Total Current Liabilities 84.12b) / Total Assets 136.89b |
| B: 0.15 (Retained Earnings 20.28b / Total Assets 136.89b) |
| C: 0.04 (EBIT TTM 5.10b / Avg Total Assets 138.16b) |
| D: 0.19 (Book Value of Equity 20.06b / Total Liabilities 107.90b) |
| Altman-Z'' Score: 1.01 = BB |
Beneish M -3.10
| DSRI: 0.95 (Receivables 3.21b/3.13b, Revenue 12.64b/11.76b) |
| GMI: 0.90 (GM 61.88% / 55.45%) |
| AQI: 1.02 (AQ_t 0.35 / AQ_t-1 0.35) |
| SGI: 1.07 (Revenue 12.64b / 11.76b) |
| TATA: -0.01 (NI 3.30b - CFO 4.66b) / TA 136.89b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of ICE shares?
As of March 24, 2026, the stock is trading at USD 157.17 with a total of 2,526,895 shares traded.
Over the past week, the price has changed by -2.36%, over one month by +2.32%, over three months by -2.64% and over the past year by -9.26%.
Over the past week, the price has changed by -2.36%, over one month by +2.32%, over three months by -2.64% and over the past year by -9.26%.
Is ICE a buy, sell or hold?
Intercontinental Exchange has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy ICE.
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ICE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 197.2 | 25.5% |
| Analysts Target Price | 197.2 | 25.5% |
ICE Fundamental Data Overview March 21, 2026
P/E Trailing = 27.4697
P/E Forward = 21.322
P/S = 9.1001
P/B = 3.113
P/EG = 2.2019
Revenue TTM = 12.64b USD
EBIT TTM = 5.10b USD
EBITDA TTM = 6.66b USD
Long Term Debt = 18.61b USD (from longTermDebt, last quarter)
Short Term Debt = 1.03b USD (from shortTermDebt, last quarter)
Debt = 20.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.44b USD (from netDebt column, last quarter)
Enterprise Value = 109.82b USD (90.37b + Debt 20.28b - CCE 837.0m)
Interest Coverage Ratio = 6.53 (Ebit TTM 5.10b / Interest Expense TTM 781.0m)
EV/FCF = 25.60x (Enterprise Value 109.82b / FCF TTM 4.29b)
FCF Yield = 3.91% (FCF TTM 4.29b / Enterprise Value 109.82b)
FCF Margin = 33.94% (FCF TTM 4.29b / Revenue TTM 12.64b)
Net Margin = 26.14% (Net Income TTM 3.30b / Revenue TTM 12.64b)
Gross Margin = 61.88% ((Revenue TTM 12.64b - Cost of Revenue TTM 4.82b) / Revenue TTM)
Gross Margin QoQ = 79.75% (prev 56.83%)
Tobins Q-Ratio = 0.80 (Enterprise Value 109.82b / Total Assets 136.89b)
Interest Expense / Debt = 0.90% (Interest Expense 182.0m / Debt 20.28b)
Taxrate = 20.47% (219.0m / 1.07b)
NOPAT = 4.05b (EBIT 5.10b * (1 - 20.47%))
Current Ratio = 1.02 (Total Current Assets 85.78b / Total Current Liabilities 84.12b)
Debt / Equity = 0.70 (Debt 20.28b / totalStockholderEquity, last quarter 28.91b)
Debt / EBITDA = 2.92 (Net Debt 19.44b / EBITDA 6.66b)
Debt / FCF = 4.53 (Net Debt 19.44b / FCF TTM 4.29b)
Total Stockholder Equity = 28.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.39% (Net Income 3.30b / Total Assets 136.89b)
RoE = 11.60% (Net Income TTM 3.30b / Total Stockholder Equity 28.49b)
RoCE = 10.82% (EBIT 5.10b / Capital Employed (Equity 28.49b + L.T.Debt 18.61b))
RoIC = 8.44% (NOPAT 4.05b / Invested Capital 48.04b)
WACC = 5.98% (E(90.37b)/V(110.65b) * Re(7.16%) + D(20.28b)/V(110.65b) * Rd(0.90%) * (1-Tc(0.20)))
Discount Rate = 7.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.54%
[DCF] Terminal Value 87.21% ; FCFF base≈4.15b ; Y1≈4.55b ; Y5≈5.82b
[DCF] Fair Price = 267.1 (EV 171.12b - Net Debt 19.44b = Equity 151.68b / Shares 567.9m; r=6.0% [WACC]; 5y FCF grow 11.12% → 3.0% )
EPS Correlation: 84.95 | EPS CAGR: 4.88% | SUE: 1.90 | # QB: 3
Revenue Correlation: 91.29 | Revenue CAGR: 6.74% | SUE: 3.66 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.90 | Chg7d=+0.013 | Chg30d=+0.021 | Revisions Net=+2 | Analysts=12
EPS current Year (2026-12-31): EPS=7.71 | Chg7d=+0.048 | Chg30d=+0.072 | Revisions Net=+2 | Growth EPS=+11.0% | Growth Revenue=+7.5%
EPS next Year (2027-12-31): EPS=8.58 | Chg7d=+0.029 | Chg30d=+0.051 | Revisions Net=+2 | Growth EPS=+11.2% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +0.4% (Analyst 4.6% - Implied 4.3%)
P/E Forward = 21.322
P/S = 9.1001
P/B = 3.113
P/EG = 2.2019
Revenue TTM = 12.64b USD
EBIT TTM = 5.10b USD
EBITDA TTM = 6.66b USD
Long Term Debt = 18.61b USD (from longTermDebt, last quarter)
Short Term Debt = 1.03b USD (from shortTermDebt, last quarter)
Debt = 20.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.44b USD (from netDebt column, last quarter)
Enterprise Value = 109.82b USD (90.37b + Debt 20.28b - CCE 837.0m)
Interest Coverage Ratio = 6.53 (Ebit TTM 5.10b / Interest Expense TTM 781.0m)
EV/FCF = 25.60x (Enterprise Value 109.82b / FCF TTM 4.29b)
FCF Yield = 3.91% (FCF TTM 4.29b / Enterprise Value 109.82b)
FCF Margin = 33.94% (FCF TTM 4.29b / Revenue TTM 12.64b)
Net Margin = 26.14% (Net Income TTM 3.30b / Revenue TTM 12.64b)
Gross Margin = 61.88% ((Revenue TTM 12.64b - Cost of Revenue TTM 4.82b) / Revenue TTM)
Gross Margin QoQ = 79.75% (prev 56.83%)
Tobins Q-Ratio = 0.80 (Enterprise Value 109.82b / Total Assets 136.89b)
Interest Expense / Debt = 0.90% (Interest Expense 182.0m / Debt 20.28b)
Taxrate = 20.47% (219.0m / 1.07b)
NOPAT = 4.05b (EBIT 5.10b * (1 - 20.47%))
Current Ratio = 1.02 (Total Current Assets 85.78b / Total Current Liabilities 84.12b)
Debt / Equity = 0.70 (Debt 20.28b / totalStockholderEquity, last quarter 28.91b)
Debt / EBITDA = 2.92 (Net Debt 19.44b / EBITDA 6.66b)
Debt / FCF = 4.53 (Net Debt 19.44b / FCF TTM 4.29b)
Total Stockholder Equity = 28.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.39% (Net Income 3.30b / Total Assets 136.89b)
RoE = 11.60% (Net Income TTM 3.30b / Total Stockholder Equity 28.49b)
RoCE = 10.82% (EBIT 5.10b / Capital Employed (Equity 28.49b + L.T.Debt 18.61b))
RoIC = 8.44% (NOPAT 4.05b / Invested Capital 48.04b)
WACC = 5.98% (E(90.37b)/V(110.65b) * Re(7.16%) + D(20.28b)/V(110.65b) * Rd(0.90%) * (1-Tc(0.20)))
Discount Rate = 7.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.54%
[DCF] Terminal Value 87.21% ; FCFF base≈4.15b ; Y1≈4.55b ; Y5≈5.82b
[DCF] Fair Price = 267.1 (EV 171.12b - Net Debt 19.44b = Equity 151.68b / Shares 567.9m; r=6.0% [WACC]; 5y FCF grow 11.12% → 3.0% )
EPS Correlation: 84.95 | EPS CAGR: 4.88% | SUE: 1.90 | # QB: 3
Revenue Correlation: 91.29 | Revenue CAGR: 6.74% | SUE: 3.66 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.90 | Chg7d=+0.013 | Chg30d=+0.021 | Revisions Net=+2 | Analysts=12
EPS current Year (2026-12-31): EPS=7.71 | Chg7d=+0.048 | Chg30d=+0.072 | Revisions Net=+2 | Growth EPS=+11.0% | Growth Revenue=+7.5%
EPS next Year (2027-12-31): EPS=8.58 | Chg7d=+0.029 | Chg30d=+0.051 | Revisions Net=+2 | Growth EPS=+11.2% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +0.4% (Analyst 4.6% - Implied 4.3%)